Navigation Links
Dr. Steven Hughes Joins Medical Ceramics Provider: C5 Medical Werks
Date:1/7/2009

ade components with an emphasis on ceramic materials. Based in the United States, the company operates an FDA registered, state-of-the-art facility with a single, comprehensive quality system certified to ISO 13485:2003, compliant with FDA's Quality System Regulation (21 CFR 820) and meeting all other applicable governmental requirements. Product lines include ceramic implantable components to be used in orthopaedic spine and dental applications, as well as other custom implant components. C5 Medical Werks excels at manufacturing premium implantable components that help people live better lives.

C5 Medical Werks is located at 2451 River Road, Grand Junction, CO 81505 USA.

For more information, please visit www.c5medicalwerks.com, e-mail info@c5medicalwerks.com, or call +1.970.683.7900.


'/>"/>
SOURCE C5 Medical Werks
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Stevens Health, Technology and Society roundtable: Sept. 19
2. Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
3. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
4. Stevens UV expert at Science-on-Saturday program
5. Northwestern Memorial Hospitals Steven J. Stryker MD Unveils Campaign With Empower Public Relations
6. Stevens chemists identify compounds to lure nutria, a rat-like pest ravaging Gulf Coast wetlands
7. WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
8. Weight Watchers Names Steven C. McCormick as President, North America
9. Norma Smith and Dr. Steven A. Stuchin honored at 2008 Founders Gala for NYU Hospital for Joint Diseases
10. MHS Announces Departure of Dr. Steven Friedman; Search for New Executive Director
11. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...alif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmace...mpanywillhosttwoinvestoreventsinDecember: ,, ...:00a.m.ET ,, Principalinvestigatorswilldiscus...and/orrefractorymultiplemyeloma,asfeaturedatthe51s...xpositioninNewOrleans,LA.Theteleconferencewillbegi...
(Date:11/25/2009)...,Md.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJan...luationandResearch,titled"ADifficultBalance-PainMa...2009issueofTheNewEnglandJournalofMedicine. ,, (.../FDALOGO ) ,, Inthearticle,WoodcockdiscussesFDA...onforthosewhoneeditandmanagingtherisksposedbyvario...
(Date:11/25/2009)...s of testicular cancer who were treated with cispl...ts, including neurological side effects and Raynau...th chemotherapy, according to a new study publishe...al Cancer Institute . , Marianne Brydy, M.D., of...Hospital, in Bergen, Norway, and colleagues conduc...
(Date:11/25/2009)...period was too short to draw definite conclusions,...ealthDay News) -- In diabetic patients with blocke...ence in outcomes at one year whether patients unde...ritish researchers report. , Bypass surgery has... with coronary artery disease. However, less invas...
(Date:11/25/2009)...ued by neurological symptoms, study finds , ...ological side effects are among the potential prob...ncer who were treated with cisplatin-based chemoth...ded 1,409 Norwegian men treated for unilateral tes... in a follow-up survey conducted from 1998 to 2002...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...ram will focus on how a small hospital improved ch...nal net revenue the first day using Craneware,s Bi... (AIM: CRW.L), the healthcare industry,s trusted p... Healthcare Information and Management Systems Soc...
...INGTON, April 2 The following is a statement from...merica,s Health (TFAH) in response to the release ...to a Healthier America by the Robert Wood Johnson... community should be safe from threats to its heal...
...on Run/Walk New York to Take Place ...May 9 , , LOS ANGELES, April 2 Revlon (NYSE: ...ndustry Foundation (EIF) announced that Revlon sp...ew York taking place on Saturday, May 2, 2009 ,...
...ladelphia, PA, 2 April 2009 Treatment with the gl..." increase in the risk of diabetic macular edema (...loss, reports a study in the April issue of the A...abetes, Drs. Donald S. Fong and Richard Contreras ...
...ch and Lomb Premium Cataract Intraocular Lenses to...00 cataract surgeons will attend a live surgery an... They will observe two surgical procedures conduct...commodating Intraocular lens (IOL) in one patient ...
...ver, Most Surveyed MCOs Say They Will Not Provide ... Stroke Prevention is Greater Convenience, Accordi...LTHAM, Mass., April 2 Decision Resources, one of ... estimate they will prescribe Bayer/Johnson & ...
Other Medicine News:Health News:Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 3Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 2Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 3Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 4Health News:Diabetes drug class linked to vision-threatening complication 2Health News:Surgeons to Observe and Discuss Live Eye Surgery Friday Night in San Francisco 2Health News:Surgeons to Observe and Discuss Live Eye Surgery Friday Night in San Francisco 3Health News:For Prevention of Stroke, Surveyed Cardiologists and PCPs Expect to Prescribe Xarelto to Approximately One-Third of Newly-Diagnosed Atrial Fibrillation Patients 2Health News:For Prevention of Stroke, Surveyed Cardiologists and PCPs Expect to Prescribe Xarelto to Approximately One-Third of Newly-Diagnosed Atrial Fibrillation Patients 3
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/...FoodandDrugAdministration(FDA)hasacceptedforreview...ept®(donepezilHClextendedrelease)tabletsforth....Thisnewhigherdoseformulationcontains23mgofdonepez...iverysystemthatallowsforgradualreleaseofthedrug.Th...
(Date:11/24/2009)..., PLEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/-...device-basedmechanicalcirculatorysupporttherapiest...itwillbeparticipatinginthe21stAnnualPiperJaffrayHe...V.Smith,executivevicepresidentandchieffinancialoff...30a.m.,EasternStandardTime(5:30a.m.,PacificStandar...
(Date:11/24/2009)..., STAMFORD,Conn.,Nov.24/PRNewswire/--ZargisMedica...aspin-offfromSiemensCorporateResearch(NYSE: SI ),t...redontheNovember24,2009episodeofCBS, TheEarlyShow ...rScience magazine,reviewedfivewinningproductsfromt... TheEarlyShow isawidely-viewedtelevisionmorningnew...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Delaying Health Care Reform is U N A C C E P T A B L E 21 52758 1Delaying Health Care Reform is U N A C C E P T A B L E 21 52758 2With Autism Diet Restrictions May Do More Harm Than Good 52756 1With Autism Diet Restrictions May Do More Harm Than Good 52756 2With Autism Diet Restrictions May Do More Harm Than Good 52756 3Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 1Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 2Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 3Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 4
...of safety and tolerability, as well as selectio...KVILLE, Md., May 30 Human Genome Sciences,Inc. (N...ed dosing in a Phase,1 clinical trial to evaluate ...tor, HGS1029, as monotherapy in patients with adva...m/cgi-bin/prnh/20080416/HGSLOGO ), "We are pleas...
... studies,reported at the American Society of Clini...fusion-related outcomes in cancer chemotherapy pat... or during administration of,erythropoiesis-stimul... using observational data from the Dosing,and Outc... (DOSE) Registry.,The first study (Larholt et al.,...
Other Medicine Technology:Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 2Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 3Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 4Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 2Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 3Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 4Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 5Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 6
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: